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There has been increasing interest in methods of suppressing immune re- 
sponses  because  of  their  great  potential  value in clinical medicine. Various 
agents are known to decrease or suppress antibody formation generally: total 
body Roentgen irradiation (1), saturation of the reficuloendothelial system with 
particulate colloidal agents such as carbon (2), protein deficiency (3), pyridoxine 
deprivation (4), and steroids (5), all have been shown to be effective. 
Recently,  compounds  that  act  as  metabolic  inhibitors  have  been  found 
useful  (6).  6-mercaptopurine  (6-MP)  is  such an  antimetabolite.  Synthesized 
as an analogue of the nucleic acid constituent, adenine, and the purine base, 
hypoxanthine, it was originally studied as an antiineoplastic agent. It antago- 
nizes purine metabolism and appears to interfere with nucleic acid synthesis (7). 
It has been demonstrated that 6-MP is effective in inhibiting the formation of 
antibody in some species of animals following stimulation with protein antigens 
(8). Using this drug, other investigators have prevented allergic encephalomye- 
litis (9), and prolonged the survival time of various tissue homografts (10, ll). 
The eye is unique in several respects. In spite of having a number of avascular 
structures it has been repeatedly demonstrated that an experimental allergic 
reaction can be readily produced by a single dose of antigen injected into the 
vitreous body. This is followed by an acute iridocyclltis appearing within 7 to 
10 days, persisting for several more days, and subsequently subsiding. In addi- 
tion, the vitreous body appears to act as a  depot for antigen with a resulting 
enhancement of antibody response (12).  Furthermore, local antibody produc- 
tion within the eye has been well documented (19).  Because of these earlier 
observations it was felt worthwhile to study the effects of 6-MP on experimen- 
tal allergic uveitis from several points of view, with an attempt to correlate 
the clinical, immunological, and histopathological findings. 
Materials  and  Methods 
New Zealand albino female rabbits weighing  2 to 4 kg were used throughout the experi- 
ments. Most animals  were obtained from a single dealer and were given a standard diet. 
* This study was supported by a research grant from the National Institutes of Health, 
Grant 2B-5317C. 
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Crystallized bovine serum albumin (Lot BX6, Pentex, Inc., Kankakee, Illinois) was used 
to induce the uveitis. A solution of 50 mg/ml in  0.85 per cent NaC1 was filtered through a 
Seitz filter, tested for sterility, and frozen in aliquots at -20°C for use as needed. 
Mter anesthetizing the rabbit with nembutal and ether, both eyes were gently massaged 
for a short while to achieve hypotony. Each eye was then injected with 0.15 ml of the antigen 
solution into the vitreous. The injection was made slowly at the region of the upper equator 
with a 27-gange needle. The amount of material lost was slight, if any. 
6-MP  (Burroughs,  Wellcome and Co., Inc., Tuckahoe, New York) at 50 mg/ml was dis- 
solved in 0.85 per cent NaC1  containing 4 ml of 10 N NaOH/100 ml. The drug was given 
daily by deep intramuscular injections into the hind limbs for 14 days at a dose of 5 mg/kg 
body weight commencing on the day that the albumin was injected  intraocularly. Control 
animals were given similar injections intramuscularly of the same diluent, without 6-MP. 
The eyes were examined in the gross,  and with the slit lamp. The uveitis was classified 0 
through 5 based on the following criteria: 
0, normal 
1, trace iris hyperemia, no other changes. 
2, mild iris injection, trace flare and ciliary flush. 
3, moderate iris hyperemia; moderate amount  of flare with ceils and  precipitate over 
lens and  cornea. 
4, large amount of iris hyperemia; flare evident in the gross;  fibrin and cells abundant; 
vitreous  opacities  present. 
5, extreme  iris  hyperemia  with  miotic pupil,  intense  photophobia,  and  lacrimation; 
extensive fibrin  deposition  and  cellular precipitates;  dense  vitreous  opacities seen 
when the interior of the eye could be observed. 
Eyes were observed prior to the experiment, several hours after injection, and daily through- 
out the experiment. Both eyes of each animal were graded, and in most cases the degree of 
uveitis was the same. Photographs of the eyes were taken at appropriate intervals. 
Control sera and aqueous samples were obtained  1 day prior to antigen administration. 
Blood samples were then collected from the ear artery on the 5th, 9th,  14th,  21st,  and 30th 
day after intraocular albumin injection. Aqueous fluid was withdrawn from the left eye only 
on similar days. Sera were heat-inactivated at 57°C for 30 minutes, and then absorbed with 
an  equal volume of washed  packed  sheep  red blood cells.  The aqueous fluid was  studied 
directly. The degree of uveitis was not usually affected by the paracenteses.  Protein deter- 
minations on the aqueous and sera were done by absorption measurements at 280 and 260 mg 
wavelengths, and  the concentration estimated  according to Kalckar.  (13)  The ratios were 
typical  for  proteins. 
The antibody titers of both fluids were determined using the hemagglutination technic of 
Boyden (14),  a~s modified by Wide and  Gemze]l (16)  for use with formalin-fixed sheep red 
blood cells.  Determination of residual antigen in the aqueous and vitreous was done by the 
hemaggiutination-inhibition  technic.  (15) 
Globes were removed at various intervals, fixed with 10 per cent formalin, embedded in 
paraffin, sectioned in the horizontal plane, and stained with hematoxylin and eosin for his- 
tologic study. Representative eyes were selected for microscopic examination. 
RESULTS 
Following  the  injection  of  bovine  serum  albumin  intraocular|y,  a  mild, 
temporary,  rapidly  developing,  inflammatory  reaction  was  produced  in  both 
the  treated  and  control  rabbits.  This  reaction  occurred  several  hours  after 
injection, remained for I  or 2 days,  and was presumed  to be due to  the  trauma E.  WIROSTKO  AND  S.  P.  HALBERT  655 
of injection. There appeared to be no difference in the severity of the reaction 
between the treated and the control group of rabbits. 
During the 5th to 9th days, the eyes of the untreated group of rabbits de- 
veloped a spontaneous inflammatory allergic reaction of varying degrees. This 
reaction reached a peak in 2 to 3 days and cleared slowly so that by the 15th 
day, most eyes were normal in the gross. The earlier the onset, the more severe 
and prolonged the inflammation tended to be. All of the twenty-seven control 
rabbits which were followed past the 9th day developed a  uveitis of varying 
severity. On the other hand, during the 14 days of treatment, most of the thirty 
rabbits  given  6-MP  showed  little  or  no  ocular  inflammation.  Nine  rabbits 
showed a  mild uveitis, while only one rabbit developed a  3+  response. The 
remaining  twenty showed no detectable reaction.  Comparison of the clinical 
TABLE I 
Inh~ri~in  E.ge~ts of 6-MP on AUergic U~dtis 
Maximum Degree of 
Uveitis (0 to 14 days)  Control  6-MP 
5+ 
4+ 
3+ 
2+ 
1+ 
0 
13" 
7 
4 
3 
1 
0 
0 
0 
1 
3 
6 
20 
Total ....................  26  30 
* Figures represent the number of animals in each category. 
results in the two groups are summarized in Table I. These data represent the 
maximum uveitis which occurred at any time after the injection and up to 14 
days. Photographs at various intervals were obtained to document the clinical 
course. Fig.  1 depicts the appearance of representative eyes of the two groups 
12 days after intraocular antigen injection. Following cessation of therapy with 
6-MP, it was of interest that eight rabbits revealed either an increased degree 
of previously existing uveitis or the appearance of a mild inflammation within 
4 to 6 days. By the end of the 30 days all eyes were quiet. The time relationship 
of the clinical events in the two groups is summarized in Text-fig. 1. The days 
charted were chosen as being most illustrative of the course of disease. 
Serum antibody titers against bovine serum albumin were determined and 
the results are given in Text-fig. 2. The sera of control animals showed a prompt 
rise to high titers within 9 days. In several rabbits, antibodies could be detected 
as early as the 5th day. By the 14th day titers were maximum and remained UVEITIS 
SUPPRESSION  OF ALLERGIC UVEITIS 
elevated  during  the  course  of  the  experiment.  Animals  treated  with  6-MP 
showed a striking suppression of antibody titer in the serum. By the 14th day 
of treatment, eight animals revealed no detectable serum antibodies, and the 
rest displayed low levels. Following cessation of the drug a slow but increasing 
titer of antibody appeared in the sera. 
The titers in aqueous fluid generally paralleled those in the serum (see Text- 
fig.  3).  However,  the  appearance  of  antibodies  in  the  aqueous  was  not  as 
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Tgxr-Fm. 1. Suppression of the clinical course of uveitis by 6-MP. BSA injected on day 0. 
The degree of uveitis (0 to Sq-) is that described in the text. Note the marked uveitis on day 
9 in the control as compared to the treated group. Each point represents one animal. 
prompt. Analysis of Text-figs. 1 to 3 reveals that there is a general correlation 
between the rise of serum and aqueous antibody titers, and the development 
of ocular inflammation in both groups. 
The maximum  degree of uveitis developing during  the  first  14 days  (the 
period of 6-MP administration), and the antibody titers in the sera are com- 
pared in Text-fig. 4.  It will be seen that  treated animals showed little or no 
uveitis and low serum antibody titers. The control animals revealed a greater 
degree  of  inflammation  and  this  was  generally associated  with  high  serum 
antibody titer levels. A  titer of 1:64 in this system appeared to represent a 
critical level of antibody associated with severe uveitis. E. WIROSTKO  AND  S.  P. HALBERT  657 
Determination of residual antigen in the vitreous and aqueous revealed that 
bovine serum albumin could be detected in these specimens  prior to  the ap- 
pearance  of  antibodies.  The  concentration of  residual  antigen  was  inversely 
proportional to the length of time after injection.  Generally no antigen could 
be detected in either the control or treated groups after the 14th day. 
There was a large variation in protein values among the aqueous samples and 
this  could be  roughly correlated  with  the intensity of uveitis  at  the time of 
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TsxT-FIo.  2. Suppression of serum antibody titers by 6-MP. BSA injected on day 0. Note 
the  prompt rise  and  plateau  in the  control  group.  Treated  animals revealed  consistently 
lower titers. 
sampling.  The  degree  of uveitis  and the aqueous protein content in the  two 
groups of animals are compared in Table II. The aqueous samples were those 
obtained at either the 9th or 14th day, at a  time when the  uveitis was most 
evident. As expected, protein determinations of sera showed no apparent differ- 
ence in values between the two groups. 
The histologic picture  of  the  control group  was  essentially  that described 
by previous investigators  (17,  18). The milder inflammatory  changes were in 
the  anterior  segment  of  the globe  (limbus,  ciliary  processes,  and  iris)  while 
the more severe reactions extended to the choroid and vitreous. With the ap- 
pearance  of  the spontaneous allergic  reaction on the 7th day the eyes of  the 658  SUPPRESSION  OF ALLERGIC UVEITIS 
control group revealed a moderate amount of mononuclear cell infiltration in 
the limbus, ciliary body, and iris. At the height of the reaction, in sections ob- 
tained during the 12th and 14th day, there was dense infiltration with lympho- 
cytes,  monocytes,  mast cells, and large undifferentiated mononuclear cells in 
the ciliary body, iris, choroid, and on the optic nerve head.  Scattered clumps 
of similar inflammatory cells were also seen in the vitreous.  Sections of eyes 
removed  on the  21st  day revealed  a  subsiding inflammatory response.  Focal 
nests  of  small  mononuclear  cells,  essentially  lymphocytes  and  plasma  cells, 
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TEXT-FIG.  3. Suppression of aqueous antibody titers by 6-MP.  Note the striking resem- 
blance of this graph to Text-fig. 2. 
persisted in the ciliary body,  vitreous,  and choroid. No other signs of active 
inflammation were present. Sections of eyes obtained on the 30th day appeared 
normal save for the scattered presence of nests of mononuclear cells observed 
previously. 
Animals  treated  with  6-MP  revealed  similar  inflammatory  responses  but 
they were less severe and were delayed in onset and course. One eye on the 9th 
day which clinically revealed beginning uveitis, displayed the typical histologic 
findings of a mild iridocyclitis much like that seen in the control rabbits. Large ~E.  WIROSTKO  AND  S.  P.  HALBERT  659 
lymphocytes, monocytes, and undifferentiated mononuclear cells were evident 
in the ciliary processes, iris, and over the optic nerve head. The specimens of 
two eyes on the 14th day revealed normal anterior segments and vitreous. The 
only significant finding was a mild infiltration of the optic nerve head with nests 
of deeply stained mononuclear cells, essentially small lymphocytes, and mono- 
cytes.  Scattered  polymorphs  and  early plasma  cells  were  occasionally  seen. 
Sections taken on the 21st day resembled those seen on the 14th day. However, 
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T~.x~-Fm. 4. A graph relating the maximum degree of uveitis to maximum sera antibody 
taters during the initial 14 days of the experiment (the time of 6-MP administration). Note 
that rabbits which developed the more severe uveifis displayed titers of 64 or greater. Each 
point represents one animal. 
the  ciliary processes  and  choroid  showed  a  scattered  infiltration  with  small 
lymphocytes. Two specimens were obtained on the 30th day.  One revealed a 
normal anterior segment but with mild infiltration of the choroid with nests of 
small deeply staining cells, presumably lymphocytes. The other eye displayed 
a mild uveifis affecting the ciliary body, choroid, and optic nerve head. Lympho- 
cytes and monocytes predominated but plasma cells and large undifferentiated 
mononuclear cells were also seen. Fig. 2 illustrates some of these findings. 
To  determine  whether  6-MP  alone  had  any significant  effect on  the  eye, 660  SUPPRESSION  OF  ALLERGIC  UV'EITIS 
three rabbits as another control were treated with 6-MP for 14 days. 0.15 ml 
of isotonic saline was injected into the left eye of each rabbit; the right eye was 
untouched. The gross clinical course and the histologic picture revealed no effect 
on normal eye structures. 
TABLE  II 
Comparison of Aqueous Fluid Findings in the Control and Treated Animals 
Degree of uveitis is that recorded at time of paracentesis. Rabbits arranged in descending 
order of severity of uveitis. The samples were obtained from individual animals on different 
days during the course of the disease, and do not necessarily represent the maximum degree 
of uveitis which developed. 
Control Untreated  6-MP-Treated 
Antibody titer  Antibody titer 
Rabbit  Degree  of  Aqueous  Rabbi  Degree  of  Aqueous 
No.  uveitis  protein  No.  uveitis  protein 
Aqueous  Serum 
n  nl 
5-5  5-t- 
6-17  5+ 
4-4  5+ 
6-20  5+ 
5--4  44- 
5-2  4+ 
5-7  4+ 
5-6  3+ 
6-7  3+ 
3--1  3+ 
5-3  3+ 
6--06  2+ 
4-5  2+ 
2-9  2+ 
6-62  2+ 
5--9  1+ 
5-25  0 
mg/ml 
4096  4096  2 +  24 
2048  256  2+  22 
1024  512  2+  12 
512  512  1+  18 
4096  2048  1+  13 
1024  1024  1+  4 
64  128  1+  1 
512  256  0  13 
256  1024  0  5 
256  512  0  3 
64  64  0  3 
128  256  0  3 
64  128  0  2 
16  8  0  1 
4  8 
128  64 
64  4 
Aqueous  Serum 
32  0 
16  64 
16  64 
32  8 
0  0 
32  16 
0  0 
32  8 
0  0 
0  0 
8  4 
32  0 
0  16 
32  8 
DISCUSSION 
These experiments clearly demonstrated that 6-MP will inhibit the appear- 
ance of allergic uveitis following a single intraocular injection of bovine serum 
albumin in rabbits. These findings were evident both at the clinical and histo- 
logical levels. The results appear to be due to interference with the immune 
response since a good correlation was demonstrated between the antibody titers 
and the height of uveitis in both the control, and 6-MP animals during the 
period of treatment. 
Following cessation of drug therapy a rise in antibody titer occurred but this 
was not usually accompanied by an apparent or significant degree of uveitis. E.  WIROSTKO  AND  S.  P.  HALBERT  661 
It may be that an insufficient amount of residual antigen was present to initiate 
the allergic reaction. 
The treated animals revealed a slow rise of serum antibody titer when 6-MP 
was discontinued, but at the termination of the experiment a significant differ- 
ence in the titers of the two groups was still clearly evident. Since the antigen 
doses were the same, it might be expected that comparable final serum antibody 
titers would be seen.  The most likely explanation, again,  is  that insufficient 
residual antigen was present to further stimulate antibody production. 
There is  no  evidence in  this  experiment to  suggest  an  anti-inflammatory 
action of 6-MP. Using steroids, Fernando (18) was able to inhibit the appear- 
ance  of uveitis in  a  similar  experimental situation.  However, he  also  noted 
that steroids suppressed the initial non-specific inflammatory response associ- 
ated with the trauma of injection. Animals treated with 6-MP in this experi- 
ment  revealed  no  significant  difference in  the  clinical  picture  or  histologic 
findings of the initial reaction to the trauma of injection when compared to the 
control group. 
The aqueous protein determinations revealed a  significantly lower content 
in treated animals. There was a rough correlation between the degree of uveitis 
and  the protein  content in  all  animals  studied.  Inasmuch  as  6-MP  did not 
alter serum protein levels, it was  felt that the lower aqueous protein values 
merely reflected the inhibition of the allergic uveifis, and was not due to any 
specific effect of the drug on the aqueous metabolism.  The findings of lower 
protein content in the treated group served as a further check on the clinical 
evidence that 6-MP suppressed the allergic uveitis. 
The histologic findings  also bore out  the  clinical findings  that  6-MP  sup- 
pressed the inflammatory allergic response. The tissue changes that appeared 
during  the  course of  therapy were less  marked  than  those  observed in  the 
controls.  During  treatment  many  eyes showed  no  uveitis  at  all.  Following 
cessation of therapy the microscopic findings were either normal or those of a 
low grade uveitis, at a  time when control specimens were showing resolution. 
At the termination of the experiment, control eyes revealed no inflammatory 
exudate, while treated specimens  revealed a  delay in  the  appearance of the 
uveitis and also, consequently, in its healing. It is important to point out that 
the specific cellular response and its manner of distribution in  tissues of the 
eye were similar in both groups. 
It is interesting to speculate on the significance that these findings may have 
in the treatment of human uveitis. It has been presumed that ocular hyper- 
sensitivity plays  an important role in  the pathology of both granulomatous 
and non-granulomatous uveitis. In the former instance, the lesions are believed 
due to both the invading pathogen and the hypersensitivity that develops to 
products of the  organism.  In the latter instance no specific organisms  have 
been incrimated, but hypersensitivity phenomena are believed to be involved. 662  SUPPRESSION  OF ALLERGIC  UVEITIS 
Non-specific treatment of the human disease has been limited almost exclusively 
to the use of corticosteroids. These drugs owe their effect in large part to an 
anti-inflammatory action.  (5)  However,  in  certain  situations  they suppress 
immune responses in large doses.  On the basis of the studies reported here, an 
evaluation  of  drugs  like  6-MP  which  primarily inhibit  antibody formation 
might be indicated for the treatment of certain forms of uveifis. 
Pyrimethamine (daraprim), a drug which is known to exert a toxoplasmacidal 
effect, has been used extensively in the treatment of toxoplasma uveitis. How- 
ever, pyrimethamine is a  folic acid antagonist, and in experimental animals 
this compound has been shown to suppress  antibody formation. (6)  It may 
well be that part of the beneficial effects seen in treatment of this disease may 
be due to the latter effect of suppressing antibody formation. Studies to de- 
termine this action of pyrimethamine are being carried out. 
SU~K~4.R¥ 
Experimental uveitis in rabbits  was induced by single intraocular antigen 
injection. Treatment with 6-MP for 14 days suppressed the allergic inflamma- 
tion and antibody response. A good correlation was demonstrated between the 
degree of uveitis and the antibody fiter. 
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EXPLANATION OF PLATES 
PLATE 85 
F~GS. 1 a  to 1 d, Photographs of representative eyes. 
FIG. 1 a. Untreated rabbit prior to intraocular injection. 
FIG. 1 b. Same untreated rabbit 12  days after intraocular bovine serum  albumin 
iniection. Note marked (5 +) inflammation. 
FIG. 1 c. 6-MP-treated rabbit prior to intraocular injection. 
FIG. 1 d. Same 6-MP rabbit 12 days after intraocular bovine serum albumin injec- 
tion. Note absence of inflammatory response. TI-IE JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 116  PLATE 85 
(Wirostko and Halbert: Suppression of allergic  uveitis) PLATE 86 
FIGS. 2 a to 2f. Comparison of histological sections from untreated, and from 6-MP- 
treated rabbits given a  single dose of bovine serum albumin intravitreally. All were 
stained with hematoxylin and eosin. (X  100). 
FIG. 2 s. Untreated allergic uveitis involving the ciliary body. 14 days after injec- 
tion. 
Fro. 2  b.  Ciliary body of 6-MP-treated rabbit.  14  days after antigen  injection THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 116  PLATE 86 
(Wirostko and Halbert:  Suppression of allergic  uveitis) PLATE 87 
FIO.  2  c.  Untreated allergic uveitis involving the choroid. 9  days  after injection. 
Retina (top) is also somewhat affected. 
FIG. 2 d. Essentially normal choroid of 6-MP-treated rabbit.  9 days after antigen 
injection. Retina (top) is normal. TIIE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 116  PLATE 87 
(Wirostko and Halbert:  Suppression of allergic  uveitis) PLATE 88 
FIG. 2  e.  Untreated allergic uveitis involving the  optic nerve head.  14  days after 
injection. 
FI6. 2 f.  Mild inflammatory response in the optic nerve head  in a  6-MP-treated 
rabbit. 14 days after antigen injection. TI~E  ~OURNAL  OF  EXPERIMENTAL  ~¢[EDICINE  VOL.  116  P~AT~  88 
(Wirostko  and  Halbert:  Suppression of allergic uveitis) 